BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23937487)

  • 1. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
    Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
    Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulators restore orthosteric agonist binding to mutated CB
    Dopart R; Kendall DA
    J Pharm Pharmacol; 2020 Jan; 72(1):84-91. PubMed ID: 31722122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
    Shore DM; Baillie GL; Hurst DH; Navas F; Seltzman HH; Marcu JP; Abood ME; Ross RA; Reggio PH
    J Biol Chem; 2014 Feb; 289(9):5828-45. PubMed ID: 24366865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
    Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
    Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
    Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
    Ahn KH; Mahmoud MM; Kendall DA
    J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
    Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
    Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum.
    Wang X; Horswill JG; Whalley BJ; Stephens GJ
    Mol Pharmacol; 2011 Apr; 79(4):758-67. PubMed ID: 21189269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical model.
    Green HM; Yang L; Zhu X; Finlay DB; Duffull SB; Glass M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5105-5118. PubMed ID: 38227196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Temporal Fingerprint for Cyclic Adenosine Monophosphate (cAMP) Signaling of Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid Receptors.
    Cawston EE; Connor M; Di Marzo V; Silvestri R; Glass M
    J Med Chem; 2015 Aug; 58(15):5979-88. PubMed ID: 26203658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
    Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
    Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
    Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).
    Kulkarni PM; Kulkarni AR; Korde A; Tichkule RB; Laprairie RB; Denovan-Wright EM; Zhou H; Janero DR; Zvonok N; Makriyannis A; Cascio MG; Pertwee RG; Thakur GA
    J Med Chem; 2016 Jan; 59(1):44-60. PubMed ID: 26529344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of the cannabinoid CB1 receptor.
    Price MR; Baillie GL; Thomas A; Stevenson LA; Easson M; Goodwin R; McLean A; McIntosh L; Goodwin G; Walker G; Westwood P; Marrs J; Thomson F; Cowley P; Christopoulos A; Pertwee RG; Ross RA
    Mol Pharmacol; 2005 Nov; 68(5):1484-95. PubMed ID: 16113085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1).
    German N; Decker AM; Gilmour BP; Gay EA; Wiley JL; Thomas BF; Zhang Y
    J Med Chem; 2014 Sep; 57(18):7758-69. PubMed ID: 25162172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
    Dopart R; Lu D; Lichtman AH; Kendall DA
    Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
    Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA
    Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1).
    Mahmoud MM; Ali HI; Ahn KH; Damaraju A; Samala S; Pulipati VK; Kolluru S; Kendall DA; Lu D
    J Med Chem; 2013 Oct; 56(20):7965-75. PubMed ID: 24053617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.